Organization
Iwate Medical University
4 abstracts
Abstract
Geriatric assessment in older patients with non-small cell lung cancer: Insights from a cluster-randomized, phase III trial—ENSURE-GA study (NEJ041/CS-Lung001).Org: St. Marianna University School of Medicine, Kagawa University Faculty of Medicine, Teine Keijinnkai Hospital, NHO Hamada Medical Center, Tokyo Metropolitan Institute for Geriatrics and Gerontology,
Abstract
Impact of exposure on outcomes with enfortumab vedotin in patients with locally advanced or metastatic urothelial cancer.Org: Pfizer Inc., Fred Hutchinson Cancer Center, Barts Cancer Institute, University of Colorado Anschutz Medical Campus, Gustave Roussy Cancer Center,
Abstract
Primary analysis of a phase II study of atezolizumab plus bevacizumab for TACE-unsuitable patients with tumor burden beyond up-to-seven criteria in intermediate-stage hepatocellular carcinoma: REPLACEMENT study.Org: Kindai University Faculty of Medicine, Osaka-Sayama, Japan, Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Hokkaido, Japan, Musashino Red Cross Hospital, Chiba University, Graduate School of Medicine, The University of Tokyo,
Abstract
Induction and concomitant chemoradiotherapy (CCRT) using modified TPF (docetaxel, cisplatin and 5-FU) for the patients with stage IVB advanced head and neck cancer.Org: Iwate Medical University, Morioka, Japan, Japan Association for Development of Community Medicine, Yahaba,